Clinical Trial Update: Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS) [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating a single subretinal injection of JWK002 gene therapy for X-linked retinoschisis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinoschisis

Drugs mentioned

• JWK002 gene therapy (JWK002)

Snippet

Sponsor: West China Hospital | Conditions: X Linked Retinoschisis | EARLY_Phase 1 | Status: RECRUITING